Bijoy P. Mathew

Bijoy P. Mathew

Auto-generated profile, based on publicly available information

Bijoy P. Mathew

Department of Chemistry, University of Delhi, Delhi 110 007, India

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BMBijoy P. Mathew
Bijoy P. Mathew
AKAwanit Kumar
Awanit Kumar
SSSatyasheel Sharma
Satyasheel Sharma
PSP.K. Shukla
P.K. Shukla
MNMahendra Nath
Mahendra Nath

11 March 2009 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
BMBijoy P. Mathew
Bijoy P. Mathew
MNMahendra Nath
Mahendra Nath

30 March 2017 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
BMBijoy P. Mathew
Bijoy P. Mathew
HYHyun Ji Yang
Hyun Ji Yang
JKJoohee Kim
Joohee Kim
JLJae Bin Lee
Jae Bin Lee
YKYun‐Tae Kim
Yun‐Tae Kim
SHSung You Hong
Sung You Hong

2 September 2009 in Journal of Heterocyclic Chemistry
Verified
Journal Article
Closed access
PDF file
BMBijoy P. Mathew
Bijoy P. Mathew
MNMahendra Nath
Mahendra Nath

14 July 2016 in Cancer Research
Verified
Journal Article
Closed access
PDF file
YZYongliang Zhang
Yongliang Zhang
JFJennifer T. Fox
Jennifer T. Fox
YPYoung-Un Park
Young-Un Park
GEGene Elliott
Gene Elliott
GRGanesha Rai
Ganesha Rai
KMKyungjae Myung
Kyungjae Myung
Impairing the division of cancer cells with genotoxic small molecules has been a primary goal to develop chemotherapeutic agents. However, DNA mismatch repair (MMR)-deficient cancer cells are resistant to most conventional chemotherapeutic agents. Here we have identified baicalein as a small molecule that selectively kills MutSα-deficient cancer cells. Baicalein binds preferentially to mismatched DNA and induces a DNA damage response in a MMR-dependent manner. In MutSα-proficient cells, baicalein binds to MutSα to dissociate CHK2 from MutSα leading to S-phase arrest and cell survival. In contrast, continued replication in the presence of baicalein in MutSα-deficient cells results in a high number of DNA double-strand breaks and ultimately leads to apoptosis. Consistently, baicalein specifically shrinks MutSα-deficient xenograft tumors and inhibits the growth of AOM-DSS–induced colon tumors in colon-specific MSH2 knockout mice. Collectively, baicalein offers the potential of an improved treatment option for patients with tumors with a DNA MMR deficiency. Cancer Res; 76(14); 4183–91. ©2016 AACR.

30 March 2017 in Angewandte Chemie
Verified
Journal Article
Closed access
PDF file
BMBijoy P. Mathew
Bijoy P. Mathew
HYHyun Ji Yang
Hyun Ji Yang
JKJoohee Kim
Joohee Kim
JLJae Bin Lee
Jae Bin Lee
YKYun‐Tae Kim
Yun‐Tae Kim
SHSung You Hong
Sung You Hong